TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

Charles L Loprinzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.